The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brain metastasis in gastroesophageal adenocarcinoma: Outcomes and molecular features.
 
Charlton Tsai
No Relationships to Disclose
 
Bastien Nguyen
Employment - Loxo
 
Anisha Luthra
No Relationships to Disclose
 
Joanne F. Chou
No Relationships to Disclose
 
Laura H. Tang
No Relationships to Disclose
 
Vivian E. Strong
No Relationships to Disclose
 
Daniela Molena
Consulting or Advisory Role - Boston Scientific; Intuitive Surgical; Johnson & Johnson; Urogen pharma
 
David Randolph Jones
Consulting or Advisory Role - AstraZeneca; Merck
 
Daniel G. Coit
No Relationships to Disclose
 
David H. Ilson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; IQvia; Lilly/ImClone; Macrogenics; Merck; Pieris Pharmaceuticals; Roche/Genentech; Taiho Pharmaceutical
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Apexigen; Bristol-Myers Squibb; I-Mab; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); MedImmune (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
Nelson S. Moss
Consulting or Advisory Role - AstraZeneca
Research Funding - GT Medical Technologies (Inst)
 
Kathryn Beal
Stock and Other Ownership Interests - Magnolia Medical Technologies; Magnolia Medical Technologies (I)
 
Marinela Capanu
No Relationships to Disclose
 
Nikolaus Schultz
No Relationships to Disclose
 
Yelena Y. Janjigian
Stock and Other Ownership Interests - Rgenix
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Imugene; Lilly; Merck; Merck Serono; Michael J. Hennessy Associates; Paradigm; Pfizer; Rgenix; Seagen; Zymeworks
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Cycle for Survival (Inst); Department of Defense (Inst); Fred's Team (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); NCI (Inst); Rgenix (Inst)
Other Relationship - Axis Medical Education; Clinical Care Options; Research to Practice
 
Steven Brad Maron
Stock and Other Ownership Interests - Calithera Biosciences
Consulting or Advisory Role - Basilea; Bicara Therapeutics; Daichi Sankyo; Natera
Research Funding - Guardant Health (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Merck